What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some ...

STAAR Surgical (STAA) stock drops as concerns over outlook overshadow the company's better-than-expected preliminary sales ...

GENEVA & LAKE FOREST, Calif.--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), ...

STAAR Surgical Company STAA stock is trading lower on Friday after reporting preliminary net sales for the second quarter of ...

Staar Surgical shares retreated after forecasting second-quarter net sales slight below Wall Street's estimate. Shares declined 12% to $25.36 in post-market trading on Thursday, after ending the ...

STAAR Surgical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.7%. The stock now trades at $27.81, marking a 16.2% gain. This was partly thanks to its ...

Staar Surgical (NASDAQ:STAA) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Staar Surgical to ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, ...

Detailed price information for Definium Therapeutics Inc (DFTX-Q) from The Globe and Mail including charting and trades.

Sand Grove's new position in STAAR Surgical represents 10.88% of its 13F assets as of September 30. Top five holdings following the filing: NYSE:TXNM: $33.54 million (16.4% of AUM) NYSE:K: $26.73 ...

Throughout the last three months, 4 analysts have evaluated Staar Surgical (NASDAQ:STAA), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table ...